Sum Up The Parts: EQWS Could Be Worth $41

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the PowerShares Russell 2000 Equal Weight Portfolio ETF ( EQWS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $40.84 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With EQWS trading at a recent price near $37.04 per unit, that means that analysts see 10.26% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of EQWS's underlying holdings with notable upside to their analyst target prices are Dimension Therapeutics Inc ( DMTX), Aptevo Therapeutics Inc ( APVO), and Eiger BioPharmaceuticals Inc ( EIGR). Although DMTX has traded at a recent price of $5.70/share, the average analyst target is 215.79% higher at $18.00/share. Similarly, APVO has 203.03% upside from the recent share price of $2.31 if the average analyst target price of $7.00/share is reached, and analysts on average are expecting EIGR to reach a target price of $32.75/share, which is 178.72% above the recent price of $11.75. Below is a twelve month price history chart comparing the stock performance of DMTX, APVO, and EIGR:

DMTX, APVO, and EIGR Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above: